BioSpace News Archive

Biotech Beach

ROTH Capital Partners to Host ROTH RNA Revolution Conference in New York City on July 17th, 2019

ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, announced today that it will host its RNA Revolution Conference on Wednesday, July 17, 2019 at the 1 Hotel Central Park in New York City.

June 28, 2019
·
3 min read
Business

Iris House and AHF to Join Forces for Women’s Health in New York and New Jersey

New affiliation between Iris House and AIDS Healthcare Foundation (AHF) seeks to improve delivery of lifesaving HIV/AIDS care and services to women throughout the New York/New Jersey metropolitan area.

June 28, 2019
·
5 min read
Biotech Beach

Biological Dynamics Receives Grant Award Funding to Advance Point-of-Care Molecular Diagnostic Platform

Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health outcomes, today announced a new grant award from the Bill & Melinda Gates Foundation.

June 28, 2019
·
2 min read
Business

Sectra Publishes Annual Report and Corporate Governance Report for 2018/2019

International medical imaging IT and cybersecurity company Sectra’s (STO: SECT B) Annual Report for the 2018/2019 fiscal year is now available at investor.sectra.com/annual-reports/.

June 28, 2019
·
1 min read
Biotech Bay

Castlight Health Achieves Two HITRUST® Certifications, Further Underscoring Commitment to Data Security and Privacy

Castlight Health, Inc. (NYSE: CSLT) today announced that it has earned two HITRUST certifications for information security.

June 28, 2019
·
2 min read
RaySearch Receives Largest Order to Date: MedAustron Chooses RayStation, RayCare and RayCommand for Two Proton and Carbon Ion Treatment Facilities

MedAustron, RaySearch’s first customer for carbon ion therapy treatment planning in RayStation back in 2012, has now decided to replace existing systems and only use RaySearch software exclusively.

June 28, 2019
·
6 min read
Pharm Country

Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD)

Pfizer Inc. (NYSE:PFE) will present initial Phase 1b clinical data on PF-06939926, an investigational gene therapy to potentially treat Duchenne muscular dystrophy (DMD) at the 25th Annual Parent Project Muscular Dystrophy (PPMD) Connect Conference in Orlando, FL.

June 28, 2019
·
10 min read
BioMidwest

EY Announces Winners for the Entrepreneur Of The Year® 2019 Heartland Awards

EY is pleased to announce the winners of the Entrepreneur Of The Year® Award in the Heartland.

June 28, 2019
·
4 min read
Business

Wauconda Physical Therapy Joins Illinois Bone & Joint Institute

Illinois Bone & Joint Institute, one of the largest independent, physician-owned orthopedic practices in the United States, is happy to announce that Wauconda Physical Therapy will be joining our practice.

June 28, 2019
·
2 min read
Business

Children’s National researchers awarded federal grants for predictive modeling of rare diseases using computation, quantitative imaging and artificial intelligence

Developing technology to more accurately predict the progression of a patient’s rare disease can help physicians choose the most effective and least invasive treatment.

June 28, 2019
·
4 min read